Skip to content
LexBuild

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research on Antimicrobial Resistance : Validation of National Committee for Clinical Laboratory Standards Breakpoints for Human Pathogens of Public Health Importance 

---
identifier: "/us/fr/02-19511"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research on Antimicrobial Resistance : Validation of National Committee for Clinical Laboratory Standards Breakpoints for Human Pathogens of Public Health Importance"
title_number: 0
title_name: "Federal Register"
section_number: "02-19511"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research on Antimicrobial Resistance : Validation of National Committee for Clinical Laboratory Standards Breakpoints for Human Pathogens of Public Health Importance"
positive_law: false
currency: "2002-08-02"
last_updated: "2002-08-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-19511"
document_type: "notice"
publication_date: "2002-08-02"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "67 FR 50442"
fr_volume: 67
docket_ids:
  - "Program Announcement 02175"
---

#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research on Antimicrobial Resistance : Validation of National Committee for Clinical Laboratory Standards Breakpoints for Human Pathogens of Public Health Importance

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Applied Research on Antimicrobial Resistance (AR): Validation of National Committee for Clinical Laboratory Standards (NCCLS) Breakpoints for Human Pathogens of Public Health Importance, PA 02175

*Times And Date:* 8:30 a.m.-9 a.m., August 22, 2002 (Open); 9:15 a.m.-12:00 p.m., August 22, 2002 (Closed).

*Place:* Atlanta Airport Hilton, 1031 Virginia Avenue, Atlanta, GA 30354.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to PA 02175.

*Contact Person for More Information:* Marsha A. Jones, Health Scientist, National Center for Infectious Diseases, CDC, 1600 Clifton Road, NE, MS C-12, Atlanta, Georgia 30333, 404-639-2603, e-mail: *[email protected].*

The Director, Management Analysis and Services Office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: July 29, 2002.

John Burckhardt,

Acting Director, Management Analysis and Services Office.